Sign in to view content

Intravitreal Gene Therapy for Neovascular AMD With ADVM-022: Results of the Phase 1 OPTIC Trial

Charles C Wykoff, MD, PhD, FASRS

Video
Published 2020

Related

One Year and Beyond: Results of Phase 1b Study of KSI-301, an AntiVEGF Antibody Biopolymer Conjugate With Extended Durability, in wAMD, DME, and RVO
Mark R. Barakat, MD
Updates from the Field
2020
OCT Angiography (OCTA) and Exudative Age-Related Macular Degeneration (ARMD)
Mark H. Nelson, MD, MBA
Updates from the Field
2017
Episode 9: Rate of Macular Atrophy in HARBOR Study with Dr. SriniVas Sadda
Keyvan Koushan, MD, FRCSC
Member Podcasts
2018

Category: AMD-Neovascular

See more